Zimmer Biomet Holdings (ZBH) Receivables (2009 - 2026)

Zimmer Biomet Holdings' Receivables history runs 18 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• On a quarterly basis, Receivables rose 12.73% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 12.73% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 15.11% from the prior year.
• Receivables climbed to $1.7 billion in Q1 2026 per ZBH's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Receivables topped out at $1.7 billion in Q1 2026 and bottomed at $1.3 billion in Q1 2022.
• The 5-year median for Receivables is $1.4 billion (2023), against an average of $1.5 billion.
• Across the five-year window, Receivables decreased 9.74% in 2022 and climbed 15.11% in 2025, its largest moves.
• Year by year, Receivables stood at $1.4 billion in 2022, then climbed by 4.41% to $1.4 billion in 2023, then rose by 2.66% to $1.5 billion in 2024, then increased by 15.11% to $1.7 billion in 2025, then increased by 1.42% to $1.7 billion in 2026.
• Per Business Quant, the three latest ZBH Receivables figures stand at $1.7 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.6 billion (Q3 2025).